Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ZAVESCA (N/R/ miglustat)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ZAVESCA (N/R/ miglustat)

Medicine - Posted on Feb 18 2011 - Updated on Jun 12 2019
Active substance (DCI)
  • miglustat
history (2)
  • 12/16/09

    ZAVESCA

    Progrès thérapeutique mineur dans le traitement des manifestations neurologiques des formes modérées de la maladie de Nieman...
    CAV :
    54321
    icône flèche
  • 11/12/03

    ZAVESCA (miglustat)

    Avis favorable à l'inscription sur la liste des médicaments agréés à l'usage des collectivités et divers services publics. ...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • A16AX06
Manufacturer
Laboratoire ACTELION PHARMACEUTICALS FRANCE
Presentation

ZAVESCA 100 mg, gélule
Boîte de 84 - Code CIP : 564 116-9

All our publications
    Central nervous system diseases Congenital, genetic and rare diseases Drug therapy Lymphatic diseases Metabolic diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
GXgMK58nnVvFNrYX